A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: LOXO-783|DRUG: Fulvestrant|DRUG: Imlunestrant|DRUG: Abemaciclib|DRUG: Anastrozole, Exemestane, or Letrozole|DRUG: Paclitaxel
Sponsor: Eli Lilly and Company
Collaborators: Loxo Oncology, Inc.